Kelman Lazarov, Inc. Pfizer Inc Transaction History

Kelman Lazarov, Inc.

$483 Million
Q1 2024

A detailed history of Kelman Lazarov, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Kelman Lazarov, Inc. holds 9,082 shares of PFE stock, worth $272,187. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,082

Previous 9,175 1.01%

Holding current value

$272,187

Previous $264,000 4.55%

% of portfolio

0.05%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$25.89 - $29.73 $2,407 - $2,764	-93 Reduced 1.01%	9,082 $252,000
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $12,777 - $16,596	-489 Reduced 5.06%	9,175 $264,000
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $2,888 - $3,375	-90 Reduced 0.92%	9,664 $320,000
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $10,221 - $11,826	283 Added 2.99%	9,754 $357,000
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $29,700 - $38,665	754 Added 8.65%	9,471 $386,000

Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $21,877 - $28,558	-524 Reduced 5.67%	8,717 $446,000
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $19,589 - $23,226	-421 Reduced 4.36%	9,241 $485,000
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $63,136 - $93,590	1,528 Added 18.79%	9,662 $571,000
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $27,578 - $31,242	-768 Reduced 8.63%	8,134 $319,000
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $18,923 - $22,201	-596 Reduced 6.28%	8,902 $327,000
Q2 2020 Jul 29, 2020	SELL	$30.12 - $36.54 $45,601 - $55,321	-1,514 Reduced 13.75%	9,498 $311,000
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $14,352 - $20,507	-531 Reduced 4.6%	11,012 $359,000
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $12,904 - $14,645	-392 Reduced 3.28%	11,543 $452,000
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $2,631 - $3,412	-81 Reduced 0.67%	11,935 $429,000
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $49,912 - $54,837	1,331 Added 12.46%	12,016 $510,000
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $57,089 - $65,088	-1,484 Reduced 12.19%	10,685 $466,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $12,581 - $15,260	-365 Reduced 2.91%	12,169 $536,000
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $178,696 - $207,312	-5,600 Reduced 30.88%	12,534 $445,000
Q4 2017 Jan 23, 2018	BUY	$33.26 - $35.29 $39,612 - $42,030	1,191 Added 7.03%	18,134 $657,000
Q3 2017 Oct 05, 2017	BUY	$31.0 - $34.15 $525,233 - $578,603	16,943	16,943 $605,000

Others Institutions Holding PFE

# of Institutions

3,160

Shares Held

3.67B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $168B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelman Lazarov, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kelman Lazarov, Inc. with notifications on news.

Account

Kelman Lazarov, Inc. Pfizer Inc Transaction History